+Search query
-Structure paper
Title | Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations. |
---|---|
Journal, issue, pages | Ann Oncol, Vol. 32, Page 261-268, Year 2021 |
Publish date | Aug 19, 2020 (structure data deposition date) |
Authors | Subbiah, V. / Shen, T. / Terzyan, S.S. / Liu, X. / Hu, X. / Patel, K.P. / Hu, M. / Cabanillas, M. / Behrang, A. / Meric-Bernstam, F. ...Subbiah, V. / Shen, T. / Terzyan, S.S. / Liu, X. / Hu, X. / Patel, K.P. / Hu, M. / Cabanillas, M. / Behrang, A. / Meric-Bernstam, F. / Vo, P.T.T. / Mooers, B.H.M. / Wu, J. |
External links | Ann Oncol / PubMed:33161056 |
Methods | X-ray diffraction |
Resolution | 1.9 - 2.06 Å |
Structure data | PDB-7ju5: PDB-7ju6: |
Chemicals | ChemComp-Q4J: ChemComp-FMT: ChemComp-HOH: ChemComp-Q6G: |
Source |
|
Keywords | Transferase/Transferase inhibitor / oncogene / RET / Tyrosine Kinase / ATP-binding / Thyroid cancer / Non small cell lung cancer / pralsetinib / Transferase-Transferase inhibitor complex / TRANSFERASE / Tyrisine Kinase / ATP binding / LOXO-292 / selpercatinib |